Take a trial of UK to unlock this pageFind out more

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 16th Apr, paid: 29th May more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +11.3%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2014, Reckitt Benckiser Group Plc revenues decreased 5% to L8.84B. Net income before extraordinary items increased 19% to L1.66B. Revenues reflect Hygiene segment decrease of 5% to L3.63B, Home Care segment decrease of 8% to L1.81B, Portfolio Brands segment decrease of 23% to L382M, Latin America, North & South Asia, Newzealand (LAPAC) segment decrease of 7% to L2.34B. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
B+
B+
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2015
31st Dec 2016

Price Target: 59.8
(+1.91% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +3.8% (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
27 brokers Broker Consensus Trend
Broker Recommendations for Reckitt Benckiser
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 2 2 10 6 7

Named Brokers and Analysts
Jefferies Martin Deboo , Credit Suisse Charlie Mills , Commerzbank Corporates & Markets Andreas Riemann , BERNSTEIN Andrew Wood , Investec Bank (UK) Plc Alex Smith , Canaccord Genuity Alicia Forry , ING FM , Nomura Securities Guillaume Delmas , Panmure Gordon Jonathan Leinster , Santander GBM , Numis Securities , Mirabaud Securities Julian Lakin , Societe Generale Iain Simpson , Berenberg James Targett , Charles Stanley Tom Gidley-Kitchin , Raymond James Euro Equities Hermine De Bentzmann , Shore Capital Stockbrokers Darren Shirley , Espirito Santo Investment Bank , Morningstar, Inc. Erin Lash , Day by Day Valérie GASTALDY , Liberum Robert Waldschmidt , BTIG , and 1 unnamed other

Profile Summary

Reckitt Benckiser Group Plc is a United Kingdom-based company engaged in manufacturing and marketing of branded health, hygiene and home products, selling a range of products through over 60 companies in nearly 200 countries. The Company’s business segments include Health, Hygiene, home and Food. Products in Health category relieve common health problems. Analgesics, cold/flu/sore throat and gastro-intestinals are over the counter medications. Health segment offers 26% of net revenues. Hygiene brands promote both personal hygiene for wellbeing and home hygiene. This segment offers 38% of the Company revenue. Home care segment includes air care products which remove malodours and fragrance the air in the home. This segment offers 20% of the Company revenue. The Company’s Food segment includes mustard, barbecue sauce, hot sauce and French Fried Onions focused primarily in North America. This segment offers 3% of the Company revenue.

Directors: Rakesh Kapoor (CEO) , Adrian Hennah (CFO) 57, Rob de Groot (EVP) , Amedeo Fasano (EVP) , Roberto Funari (EVP) , Frederic Larmuseau (EVP) , Deborah Yates (SVP) , Darrell Stein (SVP) , William Mordan (SEC) , Adrian Bellamy (NEC) 73, Gerd Harf (NVC) 69, Jaspal Bindra (NID) 53, Nicandro Durante (NID) 58, Mary Harris (NID) 48,

No. of Employees: 37,200 No. of Shareholders: n/a


Last Annual December 31st, 2014
Last Interim December 31st, 2014
Shares in Issue 714,138,778
Free Float 631.2m (88.4%)

Address 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom
Web http://www.rb.com
Phone +44 1753 217800
Contact Richard Joyce (Director - Investor Relations)
Auditors PricewaterhouseCoopers LLP

RB. Share Price Performance RB.Quote
5870p
24.0  0.4%
Traded 4:41pm · Minimum 15 min delayed · NMS: 0.300k

Latest RB. News Announcements (delayed)

Upcoming RB. Events
Monday 27th July, 2015
Half Year 2015 Reckitt Benckiser Group PLC Earnings Release
Wednesday 21st October, 2015
Q3 2015 Reckitt Benckiser Group PLC Interim Management Statement Release
Thursday 11th February, 2016
Full Year 2015 Reckitt Benckiser Group PLC Earnings Release
Friday 6th May, 2016 (estimate)
Reckitt Benckiser Group PLC Annual Shareholders Meeting

Recent ↓
Thursday 7th May, 2015
Reckitt Benckiser Group PLC Annual Shareholders Meeting
Friday 24th April, 2015
Q1 2015 Reckitt Benckiser Group PLC Trading Statement Call
Friday 24th April, 2015
Q1 2015 Reckitt Benckiser Group PLC Trading Statement Release
Wednesday 15th April, 2015
Dividend For RBGLY
Monday 16th March, 2015
Reckitt Benckiser Group PLC at CAGE Conference
Wednesday 11th February, 2015
Full Year 2014 Reckitt Benckiser Group PLC Earnings Call
Wednesday 11th February, 2015
Full Year 2014 Reckitt Benckiser Group PLC Earnings Release
Thursday 11th December, 2014
Reckitt Benckiser Group PLC Ordinary Shareholders Meeting
Monday 1st December, 2014
RB Pharmaceuticals (Indivior) Investor Day - New York
Friday 21st November, 2014
RB Pharmaceuticals (Indivior) Investor Day - London


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy RB.

Access RB. Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder